Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSC for Alport Syndrome
NCT06731192Phase 3Not yet recruiting
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of human umbilical cord mesenchymal stem cells in Alport syndrome. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Alport syndrome
Beyond the preview
Go deeper on NCT06731192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06731192.